Improving care for diabetic patients on dialysis: can using a new device to identify risk periods of ‘high’ and ‘low’ blood sugars in both hospital and home dialysis patients
- Conditions
- Renal failureUrological and Genital Diseases
- Registration Number
- ISRCTN58101486
- Lead Sponsor
- Portsmouth Hospitals NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 89
1. Male or Female aged 18 years or above
2. Diagnosis of Diabetes Mellitus requiring insulin therapy
3. On Renal Replacement Therapy for a minimum of 3 months
4. Have downloadable SGBM devise already in use
1. Acute prescription (within 2 weeks) of medication that may increase or decrease serum glucose
2. Planned change of renal replacement modality during study period
3. Co-enrolment in other studies that provided therapies or interventions that may affect glycaemia control
4. Unable to provide informed consent
Added 29/12/2016:
5. Planned x-ray, computed tomography (CT) scan, magnetic resonance imaging (MRI) or high-frequency electrical heat (diathermy) treatment during the study period
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> Primary outcome measure as of 29/12/2016:<br> Ambulatory glucose profile as generated by 14 days of interstitial glucose monitoring.<br><br> Original primary outcome measure:<br> Overall glycaemic variability is determined using interstitial glucose measurements collected by a continuous glucose monitor over a 14 day period.<br>
- Secondary Outcome Measures
Name Time Method